Showing results (421-430 of 494) with videos related to

Sort By:
Pageof 50
Elife|December 22, 2020
Phylogenomics of white-eyes, a 'great speciator', reveals Indonesian archipelago as the center of lineage diversityChyi Yin Gwee, Kritika M Garg, Balaji Chattopadhyay, et al.
Biorxiv : the Preprint Server for Biology|October 14, 2020
CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entire SARS-CoV-2 proteome and show kinetics of early differentiationHassen Kared, Andrew D Redd, Evan M Bloch, et al.
The Journal of Clinical Investigation|January 11, 2021
SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individualsHassen Kared, Andrew D Redd, Evan M Bloch, et al.
American Journal of Hematology|September 26, 2024
Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditionsJeremy W Jacobs, Garrett S Booth, Sheharyar Raza, et al.
Vox Sanguinis|March 27, 2021
Lessons learned in the collection of convalescent plasma during the COVID-19 pandemicSilvano Wendel, Kevin Land, Dana V Devine, et al.
Transfusion|May 26, 2016
Serologic screening of United States blood donors for Babesia microti using an investigational enzyme immunoassayAndrew E Levin, Phillip C Williamson, Evan M Bloch, et al.
Vox Sanguinis|June 14, 2020
Guidance for the procurement of COVID-19 convalescent plasma: differences between high- and low-middle-income countriesEvan M Bloch, Ruchika Goel, Silvano Wendel, et al.
Expert Review of Anti-Infective Therapy|January 27, 2026
COVID-19 convalescent plasma safety and efficacy analysis for biologics license application approvalDavid J Sullivan, Rita Reik, Alicia Prichard, et al.
Medrxiv : the Preprint Server for Health Sciences|October 21, 2021
Differentiation of SARS-CoV-2 naturally infected and vaccinated individuals in an inner-city emergency departmentEvan J Beck, Yu-Hsiang Hsieh, Reinaldo E Fernandez, et al.
BMC Immunology|February 17, 2022
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.
Pageof 50